A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.
pixel

DPH Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £99,235.80
Insider Selling (Last 12 Months): £245,028.96

Dechra Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Dechra Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Dechra Pharmaceuticals Share Price & Price History

Current Price: GBX 2,622
Price Change: Price Increase of +98 (3.88%)
As of 09/30/2022 01:00 AM ET

This chart shows the closing price history over time for DPH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Market Wizard Reveals: The One Ticker Retirement Plan
Introducing the “One Ticker Retirement Plan”… It’s a way to trade just one ticker…

And potentially make all the money you need – no matter what happens in the stock market.

Sounds too good to be true?
Larry reveals everything in this interview

Dechra Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/22/2022Paul SandlandInsiderSell1,936GBX 2,781£53,840.16
4/5/2022Alison PlattInsiderBuy2,346GBX 4,230£99,235.80
10/5/2021Paul SandlandInsiderSell3,960GBX 4,828£191,188.80
9/21/2021Tony GriffinInsiderSell5,346GBX 5,237£279,970.02
9/10/2021Tony GriffinInsiderSell17,500GBX 5,001£875,175
4/16/2021Tony GriffinInsiderSell25,000GBX 3,852£963,000
3/9/2021Alison PlattInsiderBuy603GBX 3,290£19,838.70
11/17/2020Ian PageInsiderSell300,000GBX 3,450£10,350,000
10/6/2020Lisa BrightInsiderBuy788GBX 3,252£25,625.76
10/1/2020Paul SandlandInsiderSell2,474GBX 3,223£79,737.02
9/22/2020Ian PageInsiderSell13,864GBX 3,148£436,438.72
9/17/2020Julian HeslopInsiderSell4,000GBX 3,248£129,920
6/11/2020Alison PlattInsiderBuy760GBX 2,609£19,828.40
See Full Table
Reclusive trader scores 20 years of winning trades. Learn how.
He had 20 straight years of winning trades without a single losing year… He had 20 straight years of winning trades without a single losing year…

And now, he is coming forward to share a brand-new forecast.
Click here to watch the video now.
pixel

SEC Filings (Institutional Ownership Changes) for Dechra Pharmaceuticals (LON:DPH)

Dechra Pharmaceuticals logo
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.
Read More on Dechra Pharmaceuticals

Today's Range

Now: GBX 2,622
Low: 2,512
High: 2,638

50 Day Range

MA: GBX 3,326.03
Low: 2,524
High: 3,784

52 Week Range

Now: GBX 2,622
Low: 2,512
High: 5,405

Volume

491,924 shs

Average Volume

328,531 shs

Market Capitalization

£2.98 billion

P/E Ratio

4,947.17

Dividend Yield

1.78%

Beta

N/A

Who are the company insiders with the largest holdings of Dechra Pharmaceuticals?

Dechra Pharmaceuticals' top insider investors include:
  1. Alison Platt (Insider)
  2. Ian Page (Insider)
  3. Lisa Bright (Insider)
  4. Paul Sandland (Insider)
  5. Tony Griffin (Insider)
Learn More about top insider investors at Dechra Pharmaceuticals.